Literature DB >> 12551713

Solvent injection as a new approach for manufacturing lipid nanoparticles--evaluation of the method and process parameters.

M A Schubert1, C C Müller-Goymann.   

Abstract

Lipid nanoparticles (LNP) can be prepared by rapidly injecting a solution of solid lipids in water-miscible solvents or a water-miscible solvent mixture into water. The aim of the present study was to evaluate the potential of this method for the preparation of LNP and the physicochemical characterization of the particles produced by this method. The results show that solvent injection is a potent and versatile approach for LNP preparation. Acetone, ethanol, isopropanol and methanol are suitable solvents in contrast to ethylacetate with which no LNP could be prepared. The obtained particle sizes (z-average) were between 80 and 300 nm depending on the preparation conditions. Up to 96.5% of the employed lipid was directly transformed into LNP. The LNP formation process seems to be diffusion controlled. Physicochemical characterization of the particles by differential scanning calorimetry (DSC), transmission electron microscopy and X-ray diffraction analysis reveals a distinct decrease in crystallinity of the colloidal lipid in comparison to the bulk lipid. Furthermore, DSC analysis of LNP hints at a delayed recrystallization of the colloidal lipid and the presence of two modifications. Therefore, a certain physical instability of the LNP has to be considered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551713     DOI: 10.1016/s0939-6411(02)00130-3

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  36 in total

1.  Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design.

Authors:  Mayank Shah; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2010-03-23       Impact factor: 3.246

2.  Liposome Formation Using a Coaxial Turbulent Jet in Co-Flow.

Authors:  Antonio P Costa; Xiaoming Xu; Mansoor A Khan; Diane J Burgess
Journal:  Pharm Res       Date:  2015-10-01       Impact factor: 4.200

3.  Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis.

Authors:  S N Shrotriya; N S Ranpise; B V Vidhate
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

Review 4.  Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.

Authors:  Surajit Das; Anumita Chaudhury
Journal:  AAPS PharmSciTech       Date:  2010-12-21       Impact factor: 3.246

5.  Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.

Authors:  Yajun Liu; Gino M Salituro; Keun-Joong Lee; Annette Bak; Dennis H Leung
Journal:  AAPS PharmSciTech       Date:  2015-02-18       Impact factor: 3.246

6.  Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention.

Authors:  Dima Alukda; Timothy Sturgis; Bi-Botti C Youan
Journal:  J Pharm Sci       Date:  2011-03-15       Impact factor: 3.534

7.  Dual Drug Delivery Using Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis.

Authors:  Rekha Devi; Ankit Jain; Pooja Hurkat; Sanjay K Jain
Journal:  Pharm Res       Date:  2015-07-22       Impact factor: 4.200

Review 8.  Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.

Authors:  Prativa Biswasroy; Deepak Pradhan; Biswakanth Kar; Goutam Ghosh; Goutam Rath
Journal:  AAPS PharmSciTech       Date:  2021-05-26       Impact factor: 3.246

Review 9.  Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.

Authors:  Melike Uner; Gülgün Yener
Journal:  Int J Nanomedicine       Date:  2007

Review 10.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.